RA
AHPI

Royce & Associates’s Allied Healthcare Products AHPI Stock Holding History

Royce & Associates’s Portfolio AHPI Stock Details AHPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1,706
Closed -$20K – 1194
2020
Q2 		$20K Buy
+1,706
New +$20.3K ﹤0.01% 1117
2015
Q4 		– Sell
-10,736
Closed -$25K – 1190
2015
Q3 		$25K Sell
10,736
-11,850
-52% -$34.7K ﹤0.01% 1185
2015
Q2 		$66K Sell
22,586
-20,913
-48% -$63.7K ﹤0.01% 1167
2015
Q1 		$142K Sell
43,499
-19,000
-30% -$61K ﹤0.01% 1146
2014
Q4 		$230K Sell
62,499
-45,750
-42% -$164K ﹤0.01% 1183
2014
Q3 		$433K Sell
108,249
-27,750
-20% -$119K ﹤0.01% 1222
2014
Q2 		$656K Hold
135,999
– – ﹤0.01% 1194
2014
Q1 		$617K Hold
135,999
– – ﹤0.01% 1210
2013
Q4 		$639K Sell
135,999
-10,000
-7% -$46.2K ﹤0.01% 1218
2013
Q3 		$660K Buy
145,999
+5,677
+4% +$28.8K ﹤0.01% 1219
2013
Q2 		$772K Buy
+140,322
New +$748K ﹤0.01% 1188

Other funds holding AHPI

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HIS
Harvest Investment Services Oakbrook Terrace, Illinois $547M AUM 64.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Royce & Associates's AHPI Position: Q3 2020 in Review

Royce & Associates sold out of Allied Healthcare Products (AHPI) in Q3 2020, closing a stake of 1,706 shares — an estimated $20K sold.

Royce & Associates first reported a position in AHPI in Q2 2013 and held it in 11 quarters. The position peaked at $772K in Q2 2013. 18 funds tracked by Wall St. Rank hold AHPI as of Q3 2020.

  • Royce & Associates reported no remaining Allied Healthcare Products position as of Q3 2020 after selling out during the quarter.
  • Royce & Associates sold 1,706 Allied Healthcare Products shares in Q3 2020, an estimated $20K.
  • Royce & Associates first reported a position in Allied Healthcare Products in Q2 2013 and held it in 11 quarters.
  • Royce & Associates's Allied Healthcare Products position peaked at $772K in Q2 2013.
  • 18 funds tracked by Wall St. Rank held Allied Healthcare Products as of Q3 2020.

Based on Royce & Associates's 13F filing for Q3 2020, filed 12 Nov 2020.